Kashiv BioSciences

Q: Where is Kashiv BioSciences located?

Kashiv BioSciences's headquarters are located at 20 New England Ave, Piscataway, New Jersey, 08854, United States

Q: What is Kashiv BioSciences's phone number?

Kashiv BioSciences's phone number is (732) 475-0500

Q: What is Kashiv BioSciences's official website?

Kashiv BioSciences's official website is www.kashivbiosciences.com

Q: What is Kashiv BioSciences's Revenue?

Kashiv BioSciences's revenue is $27.3 Million

Q: What is Kashiv BioSciences's SIC code?

Kashiv BioSciences's SIC: 28,283

Q: What is Kashiv BioSciences's NAICS code?

Kashiv BioSciences's NAICS: 32,325

Q: How many employees does Kashiv BioSciences have?

Kashiv BioSciences has 236 employees

Q: What industry does Kashiv BioSciences belong to?

Kashiv BioSciences is in the industry of: Drug Manufacturing & Research , Pharmaceuticals , Healthcare

Q: What is Kashiv BioSciences competition?

Kashiv BioSciences top competitors include: Oakwood Labs , Tris Pharma , Prolong Pharmaceuticals, LLC. , Heron Therapeutics

Q: What companies has Kashiv BioSciences acquired?

Kashiv BioSciences has acquired the companies: Adello Biologics

Business Services · New Jersey, United States · 236 Employees

View Company Info for Free

About

Headquarters

20 New England Ave, Piscataway, New Jersey, 088...

Phone Number

(732) 475-0500

Website

www.kashivbiosciences.com

Revenue

$27.3 Million

Industry

Drug Manufacturing & Research

Pharmaceuticals

Healthcare

Most Recent Scoops

Apr 17 2024

Hiring Plans

Jan 29 2024

Open Position

Kashiv BioSciences is currently seeking a Senior Director, Analytical Research Development. (Piscataway, New Jersey, 08854, United States)

See all scoops

Highlights

<$5M

Total Funding Amount

<$5M

Most Recent Funding Amount

Number of Funding Rounds

View details

Who is Kashiv BioSciences

Since its establishment in 2011, Kashiv BioSciences has evolved into a premier, fully integrated biopharmaceutical company offering next-generationdrug delivery technologies, biosimilars, and specialty biopharmaceutical products. Kashiv is built on patient-focused innovation and leverages its expertise in small and large molecules to develop a clinically differentiated pipeline of novel compounds and biosimilars with lead candidates in various therapeutic areas, including CNS, endocrinology, cancer, and several debilitating orphan diseases. Kashiv plans to commercialize its products via strategic partnerships, and for select products, through the creation of an in-house specialized sales and marketing organization.Read more

Is this data correct?

View contact profiles from Kashiv BioSciences

Popular SearchesKashiv BioSciencesKashiv Pharma LLCKashiv Biosciences LLCKashiv PharmaKashiv BioSciences IncSIC Code 28,283NAICS Code 32,325Show more

Kashiv BioSciences Org Chart

Sandeep Gupta

Chief Executive Officer

Phone

Navnit Shah

President and CSO

Phone

Chandramauli Rawal

Chief Operating Officer

Phone

Is Kashiv BioSciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Product Launch: Get notified when Kashiv BioSciences launches new products

Earning: See what the market has to say on Kashiv BioSciences recently announced quarterly report

Kashiv BioSciences, which may be a good buyer, showed buying intent in Masked Content Topic

Check out if Kashiv BioSciences is spiking on competitors!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Funding: Get notified immidiatlly once Kashiv BioSciences has new funding data

Click to see if Kashiv BioSciences had a recent Job posting/layoffs

Check if Kashiv BioSciences has recently received funding, and reach out quickly before it becomes old news!

Congratulate Masked Content for being promoted to Masked Content at Kashiv BioSciences

Website visits: Recent activity has been detected on your website

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 3 more new buyers

Compare Similar Companies to Kashiv BioSciences

Compare insights from companies similar to Kashiv BioSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Kashiv BioSciences

$27.3M

236

Heron Therapeutics

$136.4M

126

Tris Pharma

$90M

541

Prolong Pharmaceuticals, ...

$35.2M

105

Romark Laboratories L.C

$29.2M

121

Oakwood Labs

$22.8M

Biosyn

$20.2M

View Email Formats for Kashiv BioSciences

Kashiv BioSciences financials insights

Gather financial insights about Kashiv BioSciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Graph showing recent funding, most recent acquisition, and main investor information for Kashiv BioSciences.

See All Financials Insights

Kashiv BioSciences Employee Growth Rate

Graph showing projected employee growth data for Kashiv BioSciences

View Kashiv BioSciences’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Kashiv BioSciences Tech Stack

A closer look at the technologies used by Kashiv BioSciences

PHP

See more technologies

Most Recent Scoops

Apr 17 2024

Hiring Plans

Mar 15 2024

Open Position

Jan 29 2024

Open Position

Kashiv BioSciences is currently seeking a Senior Director, Analytical Research Development. (Piscataway, New Jersey, 08854, United States)

Aug 8 2023

Open Position

Kashiv BioSciences is currently seeking a Director, Manufacturing Operations. (Piscataway, New Jersey, United States)

May 19 2023

Open Position

Kashiv BioSciences is currently seeking a Director, Manufacturing Operations. (Piscataway)

See more scoops

Kashiv BioSciences News & Media

Kashiv BioSciences Appoints Dr. Sandeep Nilkanth Athalye as Global CEO
PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC, a global vertically integrated biopharmaceutical company, is pleased to announce the appointment of Dr. Sandeep Nilkanth Athalye as Global Chief Executive Officer. Dr. Athalye, a seasoned leader with over two decades of experience in strategic and operational roles within the global pharmaceutical industry, will oversee company operations and drive strategic growth across key markets, including the United States, Europe, and Asia. Dr.
Nov 1, 2024
www.businesswire.com
Kashiv BioSciences Announces Completion of Enrollment for Phase III Clinical Trial of ADL018, a Biosimilar Candidate to XOLAIR® (omalizumab)
PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC today announced the completion of patient enrollment for its Phase III clinical trial of ADL018, a biosimilar candidate to XOLAIR®. This pivotal study aims to compare the efficacy, safety, tolerability, and immunogenicity of ADL018 with XOLAIR® in patients with chronic idiopathic/spontaneous urticaria (CSU) who remain symptomatic despite taking H1 antagonists. This clinical trial enrolled total 600 patients across multiple sites globall
Jul 25, 2024
www.businesswire.com
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC (“Kashiv” or the “Company”) today announced that it has entered into an exclusive licensing agreement for ADL018, a proposed biosimilar to omalizumab referencing XOLAIR®, with Amneal Pharmaceuticals, Inc. (“Amneal”) for the United States. Omalizumab, which targets free IgE, is a humanized monoclonal antibody. It is an injectable prescription drug used to treat a number of chronic conditions such as severe persistent allergic asthma, chr
Jul 1, 2024
www.businesswire.com
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Alvotech for Development & Commercialization of a Proposed Biosimilar to Xolair® (omalizumab)
PISCATAWAY, N.J. & REYKJAVIK, Iceland--(BUSINESS WIRE)--Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company, and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have entered into an exclusive licensing agreement for ADL018 (also called AVT23), a proposed biosimilar to Xolair® (omalizumab), which is in clinical development. The agreement covers a
Oct 3, 2023
www.businesswire.com
Kashiv BioSciences Enrolls First Patient in Phase III Clinical Study for ADL018, A Biosimilar Candidate to XOLAIR® (omalizumab)
PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC (“Kashiv” or the “Company”) today announced that it has enrolled the first patient in its Phase III clinical study involving ADL018, the Company’s biosimilar candidate to XOLAIR®. The objective of the study is to compare ADL018 and XOLAIR® in terms of efficacy, safety, tolerability, and immunogenicity in patients with chronic idiopathic/spontaneous urticaria (CSU) who remain symptomatic on H1 antihistamine treatment. The study is expect
Oct 2, 2023
www.businesswire.com

Top Companies in United States

Frequently Asked Questions Regarding Kashiv BioSciences

Where is Kashiv BioSciences located?

Kashiv BioSciences's headquarters are located at 20 New England Ave, Piscataway, New Jersey, 08854, United States

What is Kashiv BioSciences's phone number?

Kashiv BioSciences's phone number is (732) 475-0500

What is Kashiv BioSciences's official website?

Kashiv BioSciences's official website is www.kashivbiosciences.com

What is Kashiv BioSciences's Revenue?

Kashiv BioSciences's revenue is $27.3 Million

What is Kashiv BioSciences's SIC code?

Kashiv BioSciences's SIC: 28,283

What is Kashiv BioSciences's NAICS code?

Kashiv BioSciences's NAICS: 32,325

How many employees does Kashiv BioSciences have?

Kashiv BioSciences has 236 employees

What industry does Kashiv BioSciences belong to?

Kashiv BioSciences is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

What is Kashiv BioSciences competition?

Kashiv BioSciences top competitors include: Oakwood Labs, Tris Pharma, Prolong Pharmaceuticals, LLC., Heron Therapeutics

What companies has Kashiv BioSciences acquired?

Kashiv BioSciences has acquired the companies: Adello Biologics

What technology does Kashiv BioSciences use?

Some of the popular technologies that Kashiv BioSciences uses are: WordPress.org, PHP, Cloudflare CDN, VMware

Who is the CEO of Kashiv BioSciences?

Kashiv BioSciences's CEO is Sandeep Gupta

How do I contact Kashiv BioSciences?

Kashiv BioSciences contact info: Phone number: (732) 475-0500 Website: www.kashivbiosciences.com

What does Kashiv BioSciences do?

What are Kashiv BioSciences social media links?

Kashiv BioSciences Linkedin page

How much funding has Kashiv BioSciences raised to date?

Kashiv BioSciences has raised <$5 Million in 1 funding round

When was the last funding round for Kashiv BioSciences?

Kashiv BioSciences closed its last funding round on Apr 08, 2020 with the amount of <$5 Million

Is Kashiv BioSciences a public company?

Kashiv BioSciences is private company therefore does not currently have an official ticker symbol

See more information about Kashiv BioSciences

Kashiv BioSciences Latest Hires and Their Positions

Kashiv BioSciences is expanding and recently hired new employees. Here are the latest additions to the team.

Sandeep Athalye

Chief Executive Officer

Joined Nov 1, 2024

Phone

Sudha Patnayak

Joined Aug 30, 2024

Phone

Payal Rathod

Quality Assurance Specialist

Joined Aug 28, 2024

Phone

Hiren Patel

Assistant Manager

Joined Aug 22, 2024

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.